Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled trial of MEDI4893 to prevent Staphylococcus aureus pneumonia in mechanically ventilated patients
2014-001097-34Phase 2Completed
- Sponsor
- MedImmune
- Start
- Jun 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Suvratoxumab in staphylococcal pneumonia, sponsored by MedImmune. Started Jun 2014; status: completed.
02
Drugs
Suvratoxumab
03
Conditions
staphylococcal pneumonia
Beyond the preview
Go deeper on 2014-001097-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001097-34.